U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07656688) titled 'Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease' on June 16.

Brief Summary: Clinical trial aims to determine the optimal dosing regimen by evaluating the efficacy and safety of HUC1-394 across different dosing frequencies in patients with moderate to severe dry eye disease.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Dry Eye Disease (DED)

Intervention: DRUG: HUC1-394

ophthalmic solution. Participants will instill 1 drop in each eye

DRUG: Placebo

ophthalmic solution. Participants will instill 1 drop in each eye

Recruitment Status: RECRUITING

Sponsor: Huons Co., Ltd.

Published by ...